Drugs&Dysphagia

-01

-02

vs

-03

PMDA 18,0002631

383 6,268 93 3,466 2,839 2,989

031700617317

-04

-05

-06

-07

-03

.etc

.etc

Quality of LifePatient-Centered OutcomesInternational Classification of Functioning

Melonpan

24

17

12

Sun-rise

-01

-02

2013

Medication-induced Dysphagia

2007910

-03

-04

1Anticholinergic Risk ScaleRudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The an

-06

GER

CaLESGERD

-07

GABA

v -fight-flight response

v

-08

(lll)

-09

+

-10

80

-11

-12

1. 2. 3. 4. 5. 6. 7.

-015

1.2.3.4.5.

Process Model (Hiiemae)

Stage Itransport

Processing

Stage transport Esophageal phase

hypopharyngeal transit time

-02

-a

-03

-b

-04

-cp

p

p

p

POINT

23115387071412

-05

-d

-06

-e 104/127 (82%) 7/56 (13%) 42/48 (87%)

124 70 67 66 46 42 32 23

76 13 6 6 5 5

1-3 494-7 348 5

1-3 344-7 282 20 5 3

-1)

2)

3)

4)

5)

ZZnn

NNSSAAIIDDss

-07

-a

-08

-b

-09

-c

,,M

MAO ,,M

..

(

GABAA/CBR ,PBR Ca2+PLC ,IP3

, D2 , K+.

D- ,.

.

1274474532006

-10

-d

. 1-2

.

Ca2+,.

1274474532006

.

-11

-e 1274474532006

Zn

Zn

D- Zn

Zn

Zn

Zn

Zn

Zn

. .

.

,

-12

-f

4

-13

-g

Mg

-()()

-1)

2)

3)

NNSSAAIIDDss

-14

-a

Logemann J.A.Logemann

-15

-b

-16

-c

Logemann JA, Smith CH, Pauloski BR, et al. : Effects of xerostomia on perception and performance of swallow function. Head Neck. 2001 Apr;23(4):317-21.

-16

-a

-17

-bam

Campbell-Taylor I. Benzodiazepines and pneumonia or aspiration pneumonitis. Thorax. 2013 Jun;68(6):591.Sliwa JA1, Lis S. Drug-induced dysphagia. Arch Phys Med Rehabil. 1993 Apr;74(4):445-7.Sokoloff LG1, Pavlakovic R. Neuroleptic-induced dysphagia. Dysphagia. 1997 Fall;12(4):177-9.

-18

-c1)2)3)

-19

-a

-20

-b1) 2) 3) 4) 5)

vNSAIDsvv

-21

-c

v Cav v v v v v

-22

1.

2. 3.

4.

5.

6.

7. 8.

9.

-01

1Anticholinergic Risk ScaleRudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The an

-02-b

-03 -a

/

EPSACH

B/P

5~20mg +++ 0 ++++ + ++ 0/+ +

50~800mg ++ + ++++ +++ + 0 +

4~16mg + +/++ 0 +++ + 0 ++

15~30mg + + ++ + 0 0 +

30~800mg +++ ++ ++ +++ 0 +++ ++

12~64mg ++ ++ + + 0 0 +

1~15mg + +++ + + 0 0 0

1~10mg + +++ + + 0 0 ++

+++++++++++

-04-b

, . .. Vol. 17 (2004-2005) No. 3 P 399-405

15.9, 665.6.10, , , , ., , 1.6., 8., , , ., .

n=14

n=10

0.670.480.380.170.440.38

0.240.090.240.110.210.06

p

-05

40

-06

1121

40